GRIN2B and stroke disorder: Ifenprodil, an NR2B subtype-selective NMDA receptor antagonist and known neuroprotectant in stroke models [13], was neuroprotective in our primary screen but was just below the cutoff for being considered a hit (z-score of 2.916).